ClinicalTrials.gg
CompletedNCT07691112Updated Jul 8, 2026

Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms

An observational study in Healthy, Autonomic Nervous System Diseases and Lymphatic Diseases, sponsored by The Touro College and University System. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by The Touro College and University System · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
101
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 49 studies in Autonomic Nervous System Diseases with a site in United States — 12 open to participants now, 16 under way, none of them phase 3. Autonomic Nervous System Diseases · United States.

Enrollment
6th of 18
101 · median 63
Started
2020
with 1 other
Observational
18 of 49
3 open now
Registered
48th of 49
by date

Among the 49 studies in Autonomic Nervous System Diseases with a site in United States, this one is the 6th largest by enrollment of the 18 observational ones that give a count, is one of 2 that started in 2020, is one of 18 observational ones, and was the 48th registered.

Autonomic Nervous System Diseases

108 studies on the registry are indexed under Autonomic Nervous System Diseases; 29 are open to participants now.

Browse Autonomic Nervous System Diseases studies →

Open to participants now

12 of the 49 studies in Autonomic Nervous System Diseases with a site in United States are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 21 Autonomic Nervous System Diseases studies recruiting now, 6 (29%) set no upper age limit and 12 (57%) stop at 75 or younger; 6 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Autonomic Nervous System Diseases with a site in United States, or all of them as a file.
02

Study summary

Chapman Reflex Points (CRPs) are small palpable nodules found within connective tissue that have traditionally been associated with dysfunction of internal organs and the autonomic nervous system. However, little is known about how commonly these findings occur in healthy individuals or whether they are associated with symptoms experienced by otherwise healthy people.

The purpose of this study is to determine the prevalence of Chapman Reflex Points in young healthy adults and to evaluate whether the presence and distribution of these points are associated with self-reported visceral symptoms. Participants complete a standardized health questionnaire regarding recent and recurrent symptoms and undergo a blinded physical examination of established Chapman Reflex Point locations performed by a trained investigator. The results of this study may improve understanding of the physiological mechanisms underlying Chapman Reflex Points and help clarify their potential role in preventive osteopathic assessment and early identification of altered autonomic, lymphatic, fascial, or neuroendocrine function.

Read the detailed description

Chapman Reflex Points (CRPs) are discrete palpable nodules located within deep fascial tissues that have historically been interpreted as viscerosomatic reflex manifestations associated with dysfunction of specific internal organs. Traditional osteopathic models suggest that CRPs develop secondary to altered autonomic activity and lymphatic dysfunction resulting from visceral pathology. More recent mechanobiological investigations have proposed that fascial contractility mediated by myofibroblasts, sympathetic regulation of lymphatic vessel function, connective tissue remodeling, and neuroendocrine influences may contribute to the formation and persistence of these palpable findings.

Despite their longstanding use in osteopathic diagnosis and treatment, there is limited evidence regarding the prevalence of CRPs in healthy individuals, and relatively few studies have investigated whether the presence of CRPs correlates with self-reported visceral symptoms in populations without significant underlying disease. Improved characterization of CRP prevalence and symptom associations may provide insight into whether these findings represent markers of overt pathology, subclinical physiological modulation, or normal biological variation.

This study was designed as a cross-sectional observational investigation to evaluate the prevalence and distribution of CRPs in a young adult population and to explore potential relationships between CRP findings and participant-reported visceral symptoms. Participants completed a standardized health questionnaire designed to assess demographic characteristics, medical history, lifestyle factors, and recent or recurrent symptoms across multiple organ systems. Following questionnaire completion, participants underwent a systematic palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent palpatory techniques, including standardized pressure application and examination duration, were utilized to improve examination reproducibility.

Participant data were recorded using anonymized study identification numbers to maintain confidentiality. Statistical analyses were performed using Microsoft Excel and STATA software. Descriptive statistics were used to characterize participant demographics and CRP prevalence. Sex-based differences in total CRP counts were evaluated using Welch's two-sample t-test. Associations between individual Chapman Reflex Points and symptom clusters were assessed using stepwise regression analyses, while relationships between grouped CRPs and grouped visceral symptom scores were examined using bivariate linear regression techniques. Statistical significance was defined as a two-sided p-value of less than 0.05.

The findings from this study are intended to contribute to a contemporary understanding of Chapman Reflex Point physiology by integrating concepts related to autonomic regulation, lymphatic function, fascial mechanotransduction, and endocrine modulation. Further investigation may help clarify the potential utility of CRPs as markers of early physiological alterations and inform their role in preventive osteopathic assessment and individualized patient evaluation.

03

Conditions studied

  • Healthy
  • Autonomic Nervous System Diseases
  • Lymphatic Diseases
  • Somatic Dysfunction
  • Chapman Reflex Points

Keywords

  • Chapman Reflex Points
  • Chapman Reflexes
  • Somatic Dysfunction
  • Viscerosomatic Reflexes
  • Osteopathic Medicine
  • Osteopathic Manipulative Medicine
  • Fascial Tissue
  • Myofibroblasts
  • Lymphatic System
  • Lymphatic Physiology
  • Autonomic Nervous System
  • Sympathetic Nervous System
  • Neuroendocrine Regulation
  • Mechanotransduction
  • Connective Tissue
  • Palpatory Examination
  • Visceral Symptoms
  • Fascia
  • Preventive Medicine
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Young adult volunteers recruited from an osteopathic medical school community participated in this cross-sectional observational study. Participants completed a standardized questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms, followed by a blinded palpatory examination of established Chapman Reflex Point locations performed by a trained investigator. A total of 101 participants were enrolled, with a mean age of 27 years.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older.
  • Ability to understand the study procedures and provide .
  • Willingness to complete a standardized health questionnaire.
  • Willingness to undergo a blinded palpatory examination of established Chapman Reflex Point locations.

Exclusion criteria

Exclusion Criteria:

  • Individuals younger than 18 years of age.
  • Inability or unwillingness to provide .
  • Inability or unwillingness to complete the health questionnaire.
  • Inability or unwillingness to undergo the palpatory examination.
  • Pregnancy.
  • Incomplete study data or questionnaire responses.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
101 participants (actual)
Patient registry
No

Groups and cohorts

  • Healthy Young Adults

    Participants were young adults who completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms. Participants subsequently underwent a blinded palpatory examination of established Chapman Reflex Point locations performed by a trained investigator. No therapeutic intervention was administered. The study evaluated the prevalence and distribution of Chapman Reflex Points and their associations with self-reported visceral symptom clusters.

    Procedure: Chapman Reflex Point Examination

Interventions

  • ProcedureChapman Reflex Point Examination

    Participants underwent a standardized palpatory examination of established Chapman Reflex Point locations performed by a single trained investigator who was blinded to questionnaire responses. Consistent pressure application and examination duration were utilized to optimize reliability and reproducibility of palpatory findings. No therapeutic intervention, osteopathic manipulative treatment, medication administration, or other clinical intervention was provided as part of the study. Participants also completed a standardized health questionnaire assessing demographic characteristics, medical history, lifestyle factors, and recent or recurrent visceral symptoms.

    Also known as: Chapman Reflex Point Assessment, Palpatory Examination of Chapman Reflex Points

06

What researchers measure

Primary outcomes

  1. Prevalence of Chapman Reflex Points

    The prevalence and distribution of Chapman Reflex Points identified during a standardized palpatory examination of established Chapman Reflex Point locations performed by a blinded trained investigator. The total number of Chapman Reflex Points observed per participant was recorded and summarized using descriptive statistics.

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Association Between Chapman Reflex Points and Visceral Symptom Clusters

    Associations between organ system-specific Chapman Reflex Point counts and self-reported visceral symptom clusters were evaluated using stepwise regression analyses and bivariate linear regression models.

    Time frame: through study completion, an average of 1 year

  2. Sex Differences in Chapman Reflex Point Prevalence

    Differences in the total number of Chapman Reflex Points identified among male and female participants were assessed using Welch's two-sample t-test.

    Time frame: through study completion, an average of 1 year

Other outcomes

  1. Distribution of Organ System-Specific Chapman Reflex Points

    The frequency of Chapman Reflex Points corresponding to individual organ systems, including pulmonary and lower gastrointestinal groupings, was assessed descriptively.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Touro College of Osteopathic Medicine - Harlem
    New York, New York 10027, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2020 to primary completion in Jun 2026, 75 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2026
First posted
Jul 8, 2026
StartActual
Mar 4, 2020
Primary completionActual
Jun 26, 2026
CompletionActual
Jun 27, 2026
Last update
Jul 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07691112
Lead sponsor
The Touro College and University System
Responsible party
Mikhail Volokitin, MD, DO. (Associate Professor of Osteopathic Manipulative Medicine, The Touro College and University System) — Principal investigator
First posted
Jul 8, 2026
Start date
Mar 4, 2020
Primary completion
Jun 26, 2026
Completion
Jun 27, 2026
Last update
Jul 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion